
Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price
Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc OMDA with a Buy rating. Check out other analyst stock ratings. Canaccord Genuity: Omada’s AI virtual care platform is "differentiated in a competitive chronic-care market,…